Analysis of profitability in the diagnosis of allergy to beta-lactam antibiotics

L. Ferré Ybarz; Ramón Salinas Argente; C. Gómez Galán; Pilar Duocastella i Selvas; Santiago Nevot Falcó

Ayuda

Analysis of profitability in the diagnosis of allergy to beta-lactam antibiotics

L. Ferré-Ybarz ^[1] ; R. Salinas Argente ^[2] ; C. Gómez Galán ^[1] ; P. Duocastella Selvas ^[1] ; S. Nevot Falcó ^[1]
1. [1] Hospital Sant Joan de Deu
  
  Hospital Sant Joan de Deu
  
  Barcelona, España
2. [2] Banc de Sang i Teixits Catalunya Central i Vallès Occidental
Localización: Allergologia et immunopathologia: International journal for clinical and investigate allergology and clinical immunology, ISSN-e 1578-1267, ISSN 0301-0546, Vol. 43, Nº. 4 (July–August), 2015, págs. 369-375
Idioma: inglés
Texto completo no disponible (Saber más ...)
Resumen
- Drug allergy is the third most common reason for allergy consultations. There is a tendency to call any adverse drug reaction (ADR) allergic, even without confirmatory allergy study.
  
  Objectives (1) Evaluate time of resolution allergy to beta-lactam's study in a sample of 100 patients. (2) Analyse cost-effectiveness of current diagnostic study (skin tests, specific IgE and drug provocation test (DPT)). (3) Describe type and frequency of ADRs in adult/paediatric patients. (4) Compare cost of complete study with DPT. (5) Assess the need to restructure current study methodology according to results obtained.
  
  The study is part of a strategic plan of the allergy department (2005–2010). Patients with suspected allergy to beta-lactams were included. Procedures performed: medical history, specific IgE, skin tests and DPT. Cost/patient analysis. Cost of protocol analysis for current diagnostic/direct DPT.
  
  Results 100 patients were studied, 52 females/48 males; 43 children/57 adults. Symptoms: 89 cutaneous, 4 anaphylaxis, 3 vasovagal reactions, 6 non-specific symptoms and 4 not recalled. Allergy was confirmed in six patients (only one child). Complete-study cost: 149.3 Euros/patient. DPT-study cost: 97.19 Euros/patient (34.9% less). Resolution time 9–13 months, absenteeism 28.04%.
  
  Conclusions In the series studied, diagnosis of allergy to beta-lactams was confirmed in 6% of patients (2.3% of paediatric patients). After analysing results and cost of the study we believe that we should propose a specific diagnostic algorithm in those paediatric patients without suspected IgE-mediated ADR, and for those patients direct DPT should be conducted. This will reduce cost/patient (−34.9%), time of resolution and absenteeism.